Q&A With King & Spalding's Seth Lundy

Law360, New York (April 23, 2012, 5:04 PM EDT) -- Seth H. Lundy is a partner in King & Spalding LLP's Washington, D.C., office, where he is deputy chairman of the firm's U.S. Food and Drug Administration and life sciences practice. He focuses his practice on health care matters involving the regulation of medical device and pharmaceutical manufacturers and health care providers and suppliers, including corporate compliance, the Anti-Kickback Statute, the Stark Law, False Claims Acts, state law compliance, transparency requirements, and Medicare and Medicaid reimbursement.

He works closely with industry and regulators on creating, revising...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.